Giuseppe Ippolito

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	60934	32028
h-endeksi	106	72
i10-endeksi	553	324

9000

4500

2250

6750

19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025156 195 227 283 368 443 629 721 778 846 911 938 1000 1015 1117 1312 1616 1773 1979 2638 2867 2889 3019 7008 8009 7073 5348 3881 563

Genel erişim

Tümünü görüntüle

304 makale

14 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Maria Rosaria CapobianchiINMI Spallanzaniinmi.it üzerinde doğrulanmış e-posta adresine sahip
vincenzo puroIstituto Spallanzani Romainmi.it üzerinde doğrulanmış e-posta adresine sahip
Emanuele NicastriINMI Spallanzaniinmi.it üzerinde doğrulanmış e-posta adresine sahip
Enrico GirardiDirector Epidemiology, INMI Spallanzani, Rome, Italyinmi.it üzerinde doğrulanmış e-posta adresine sahip
Professor Sir Alimuddin ZumlaUniversity College Londonucl.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Concetta CastillettiBiologist, Laboratory of Virology, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzaniinmi.it üzerinde doğrulanmış e-posta adresine sahip
Antonino Di CaroUnicamillus International Medical University in Romeunicamillus.org üzerinde doğrulanmış e-posta adresine sahip
Andrea AntinoriDirector HIV/AIDS Unit - INMI - National Institute for Infectious Diseases L. Spallanzani, Romainmi.it üzerinde doğrulanmış e-posta adresine sahip
Francesco VairoNationa Institute for Infectious Diseases INMI "L.Spallanzani"inmi.it üzerinde doğrulanmış e-posta adresine sahip
Simone LaniniUniversity of Udine - Department of Medicineuniud.it üzerinde doğrulanmış e-posta adresine sahip
Gabriella De CarliIstituto Nazionale per le Malattie Infettive L. Spallanzani IRCCSinmi.it üzerinde doğrulanmış e-posta adresine sahip
Goletti DeliaTranslational Research Unit, INMIinmi.it üzerinde doğrulanmış e-posta adresine sahip
mauro piacentiniProfessor of Cell Biology, University of Rome "Tor Vergata" and IRCCS "L Spallanzani"uniroma2.it üzerinde doğrulanmış e-posta adresine sahip
Licia BordiDirigente biologoinmi.it üzerinde doğrulanmış e-posta adresine sahip
Pierluca PiselliINMI "L. Spallanzani" IRCCS, Department of Epidemiologyinmi.it üzerinde doğrulanmış e-posta adresine sahip
Antonella D'Arminio Monforteunimi.it üzerinde doğrulanmış e-posta adresine sahip
Silvia MeschiPhD INMI L. Spallanzaniinmi.it üzerinde doğrulanmış e-posta adresine sahip
Paola ScognamiglioIstituto Nazionale Malattie Infettive "L.Spallanzani" IRCCS Rome Italyinmi.it üzerinde doğrulanmış e-posta adresine sahip
Carla Nisiiresearcher, L. Spallanzani National Institute for Infectious Diseasesinmi.it üzerinde doğrulanmış e-posta adresine sahip
Claudio AngelettiIstituto Nazionale Malattie Infettive "L. Spallanzani" Romainmi.it üzerinde doğrulanmış e-posta adresine sahip

Takip et

Giuseppe Ippolito

Scientific Director - INMI- National Institute for Infectious Diseases Lazzaro Spllanzani

inmi.it üzerinde doğrulanmış e-posta adresine sahip

infectious diseases


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹ DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021	11052	2021
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China DS Hui, EI Azhar, TA Madani, F Ntoumi, R Kock, O Dar, G Ippolito, ... International journal of infectious diseases 91, 264-266, 2020	4251	2020
COVID-19 infection: the perspectives on immune responses Y Shi, Y Wang, C Shao, J Huang, J Gan, X Huang, E Bucci, M Piacentini, ... Cell Death & Differentiation 27 (5), 1451-1454, 2020	1899	2020
A case–control study of HIV seroconversion in health care workers after percutaneous exposure DM Cardo, DH Culver, CA Ciesielski, PU Srivastava, R Marcus, ... New England Journal of Medicine 337 (21), 1485-1490, 1997	1870	1997
COVID-19, SARS and MERS: are they closely related? N Petrosillo, G Viceconte, O Ergonul, G Ippolito, E Petersen Clinical microbiology and infection 26 (6), 729-734, 2020	1448	2020
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ... Aids 14 (5), 499-507, 2000	777	2000
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, P De Longis, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (5), 445-449, 2001	674	2001
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ... Nature medicine 27 (10), 1752-1760, 2021	521	2021
Rapid spread of Zika virus in the Americas-implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games E Petersen, ME Wilson, S Touch, B McCloskey, P Mwaba, M Bates, O Dar, ... International Journal of Infectious Diseases 44, 11-15, 2016	506	2016
Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma B McCloskey, A Zumla, G Ippolito, L Blumberg, P Arbon, A Cicero, ... The Lancet 395 (10230), 1096-1099, 2020	498	2020
SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection F Colavita, D Lapa, F Carletti, E Lalle, L Bordi, P Marsella, E Nicastri, ... Annals of internal medicine 173 (3), 242-243, 2020	474	2020
Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses D Raoult, A Zumla, F Locatelli, G Ippolito, G Kroemer Cell stress 4 (4), 66, 2020	443	2020
The risk of occupational human immunodeficiency virus infection in health care workers: Italian multicenter study G Ippolito, V Puro, G De Carli Archives of internal medicine 153 (12), 1451-1458, 1993	420	1993
Immunological and inflammatory profiles in mild and severe cases of COVID-19 JW Song, C Zhang, X Fan, FP Meng, Z Xu, P Xia, WJ Cao, T Yang, XP Dai, ... Nature communications 11 (1), 3410, 2020	419	2020
Clinical management of Ebola virus disease in the United States and Europe TM Uyeki, AK Mehta, RT Davey Jr, AM Liddell, T Wolf, P Vetter, ... New England Journal of Medicine 374 (7), 636-646, 2016	411	2016
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies S Tiberi, N Du Plessis, G Walzl, MJ Vjecha, M Rao, F Ntoumi, S Mfinanga, ... The Lancet Infectious Diseases 18 (7), e183-e198, 2018	405	2018
Risk factors for tuberculosis in HIV-lnfected persons: a prospective cohort study G Antonucci, E Girardi, MC Raviglione, G Ippolito, P Almi, G Angarano, ... Jama 274 (2), 143-148, 1995	389	1995
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ... Nature 524 (7563), 97-101, 2015	384	2015
Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016 E Nicastri, C Castilletti, G Liuzzi, M Iannetta, MR Capobianchi, G Ippolito Eurosurveillance 21 (32), 30314, 2016	359	2016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects A Zumla, M Rao, RS Wallis, SHE Kaufmann, R Rustomjee, P Mwaba, ... The Lancet Infectious Diseases 16 (4), e47-e63, 2016	335	2016

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar